Taking together, we demonstrate that EPIC can activate ERBIN gene expression by perturbing the HOTAITR-EZH2 interaction, which in turn inhibits the activation of RAS signaling and tumor growth in vitro and in vivo. The gene discussed is EZH2; the disease is neoplasm.